Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Microglia regulate blood clearance in subarachnoid hemorrhage by heme oxygenase-1
Nils Schallner, … , Leo E. Otterbein, Khalid A. Hanafy
Nils Schallner, … , Leo E. Otterbein, Khalid A. Hanafy
Published May 26, 2015
Citation Information: J Clin Invest. 2015;125(7):2609-2625. https://doi.org/10.1172/JCI78443.
View: Text | PDF
Research Article Neuroscience

Microglia regulate blood clearance in subarachnoid hemorrhage by heme oxygenase-1

  • Text
  • PDF
Abstract

Subarachnoid hemorrhage (SAH) carries a 50% mortality rate. The extravasated erythrocytes that surround the brain contain heme, which, when released from damaged red blood cells, functions as a potent danger molecule that induces sterile tissue injury and organ dysfunction. Free heme is metabolized by heme oxygenase (HO), resulting in the generation of carbon monoxide (CO), a bioactive gas with potent immunomodulatory capabilities. Here, using a murine model of SAH, we demonstrated that expression of the inducible HO isoform (HO-1, encoded by Hmox1) in microglia is necessary to attenuate neuronal cell death, vasospasm, impaired cognitive function, and clearance of cerebral blood burden. Initiation of CO inhalation after SAH rescued the absence of microglial HO-1 and reduced injury by enhancing erythrophagocytosis. Evaluation of correlative human data revealed that patients with SAH have markedly higher HO-1 activity in cerebrospinal fluid (CSF) compared with that in patients with unruptured cerebral aneurysms. Furthermore, cisternal hematoma volume correlated with HO-1 activity and cytokine expression in the CSF of these patients. Collectively, we found that microglial HO-1 and the generation of CO are essential for effective elimination of blood and heme after SAH that otherwise leads to neuronal injury and cognitive dysfunction. Administration of CO may have potential as a therapeutic modality in patients with ruptured cerebral aneurysms.

Authors

Nils Schallner, Rambhau Pandit, Robert LeBlanc III, Ajith J. Thomas, Christopher S. Ogilvy, Brian S. Zuckerbraun, David Gallo, Leo E. Otterbein, Khalid A. Hanafy

×

Figure 7

Exogenous CO gas treatment reduces neuronal injury after SAH in WT mice.

Options: View larger image (or click on image) Download as PowerPoint
Exogenous CO gas treatment reduces neuronal injury after SAH in WT mice....
(A) Representative (n = 6) H&E-stained cross sections (original magnification, ×40) of the MCA 7 days after SAH in WT mice treated with RA or CO. (B) Quantification of MCA vasospasm, defined as the quotient of LR and WL. *P = 0.024 for SAH plus RA versus SAH plus CO (2-tailed Student’s t test; n = 6). (C and D) Quantification of cleaved caspase-3–positive cells per microscopic view in the DG (C; *P = 0.0382) and cortex (D; *P = 0.0323) for SAH plus RA versus SAH plus CO (2-tailed Student’s t test; n = 6). (E) Number of total errors in spatial memory function by Barnes maze assessment. Graphs show test results on the days after spatial reversal. *P = 0.022 (day 0) for SAH plus RA versus SAH plus CO and **P = 0.0155 (day 2) (2-way ANOVA; n = 9). (F) Total latency in seconds for spatial memory function by Barnes maze assessment. *P = 0.0014 (day 2) and **P = 0.0417 (day 3) (2-way ANOVA; n = 9). (G) Total latency in seconds for spatial memory function by Morris water maze assessment. *P = 0.0005 (day 0); **P = 0.0054 (day 1); ***P = 0.0012 (day 2); and #P = 0.0479 (day 3) (2-way ANOVA; n = 9). (H) Representative (n = 3) MRIs of mice with intracranial injection of gadopentetate dimeglumine–labeled blood with or without CO treatment. (I) Quantification of radiographically assessed hematoma volume in mice treated with RA or CO. *P = 0.0277 (2-tailed Student’s t test; n = 3).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts